Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard P Shannon

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Transactions of the American Clinical and Climatological Association|June 21, 2011
Eliminating hospital acquired infections: is it possible? Is it sustainable? Is it worth it?Richard P Shannon
Diabetes|March 23, 2013
DPP-4 inhibition and neuroprotection: do mechanisms matter?Richard P Shannon
American Journal of Therapeutics|January 24, 2006
Managing atherosclerosis in patients with type 2 diabetes mellitus and metabolic syndromeSuneetha Venkatapuram, Richard P Shannon
Reviews in Cardiovascular Medicine|December 12, 2003
Insulin resistance in dilated cardiomyopathyAnkur Shah, Richard P Shannon
Circulation|February 24, 2006
Bacteria and coronary atheroma: more fingerprints but no smoking gunJoel T Katz, Richard P Shannon
Respiratory Care|July 3, 2008
Building a better intensive care unit: the role of industrial process improvement in critical careJeremy M Kahn, Richard P Shannon
The American Journal of Cardiology|January 8, 2008
Improving medication compliance in patients with heart failureSuzanne B Brown, Richard P Shannon
The American Journal of Managed Care|May 5, 2012
Chasing high performance: best business practices for using health information technology to advance patient safetyJennifer S Myers, Richard P Shannon
The Journal of Endocrinology|August 9, 2013
Incretin-based therapies: can we achieve glycemic control and cardioprotection?Franca S Angeli, Richard P Shannon
Frontiers of Hormone Research|June 20, 2014
Beyond glycemic control: cardiovascular effects of incretin-based therapiesFranca S Angeli, Richard P Shannon
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Transactions of the American Clinical and Climatological Association|June 21, 2011
Eliminating hospital acquired infections: is it possible? Is it sustainable? Is it worth it?Richard P Shannon
Diabetes|March 23, 2013
DPP-4 inhibition and neuroprotection: do mechanisms matter?Richard P Shannon
American Journal of Therapeutics|January 24, 2006
Managing atherosclerosis in patients with type 2 diabetes mellitus and metabolic syndromeSuneetha Venkatapuram, Richard P Shannon
Reviews in Cardiovascular Medicine|December 12, 2003
Insulin resistance in dilated cardiomyopathyAnkur Shah, Richard P Shannon
Circulation|February 24, 2006
Bacteria and coronary atheroma: more fingerprints but no smoking gunJoel T Katz, Richard P Shannon
Respiratory Care|July 3, 2008
Building a better intensive care unit: the role of industrial process improvement in critical careJeremy M Kahn, Richard P Shannon
The American Journal of Cardiology|January 8, 2008
Improving medication compliance in patients with heart failureSuzanne B Brown, Richard P Shannon
The American Journal of Managed Care|May 5, 2012
Chasing high performance: best business practices for using health information technology to advance patient safetyJennifer S Myers, Richard P Shannon
The Journal of Endocrinology|August 9, 2013
Incretin-based therapies: can we achieve glycemic control and cardioprotection?Franca S Angeli, Richard P Shannon
Frontiers of Hormone Research|June 20, 2014
Beyond glycemic control: cardiovascular effects of incretin-based therapiesFranca S Angeli, Richard P Shannon
Pageof 7